Vertex Pharmaceuticals, Inc’s recently made public that its Director Bhatia Sangeeta N. unloaded Company’s shares for reported $0.1 million on Aug 27 ’25. In the deal valued at $386.69 per share,266 shares were sold. As a result of this transaction, Bhatia Sangeeta N. now holds 4,565 shares worth roughly $1.76 million.
Then, Bhatia Sangeeta N. bought 266 shares, generating $102,860 in total proceeds.
Before that, Kewalramani Reshma bought 10,000 shares. Vertex Pharmaceuticals, Inc shares valued at $3,895,768 were divested by the CEO & President at a price of $389.58 per share. As a result of the transaction, Kewalramani Reshma now holds 115,968 shares, worth roughly $44.73 million.
Leerink Partners upgraded its Vertex Pharmaceuticals, Inc [VRTX] rating to an Outperform from a a Market perform in a research note published recently. A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in early September with a ‘”a Mkt perform”‘ rating. Wells Fargo also remained covering VRTX and has increased its forecast on August 06, 2025 with a “an Overweight” recommendation from previously “an Equal weight” rating. Wolfe Research revised its rating on May 07, 2025. It rated VRTX as “a Peer perform” which previously was an “an Outperform”.
Price Performance Review of VRTX
On Friday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock jump 1.01% to $385.73. Over the last five days, the stock has gained 0.68%. Vertex Pharmaceuticals, Inc shares have fallen nearly -16.69% since the year began. Nevertheless, the stocks have fallen -4.21% over the past one year. While a 52-week high of $519.88 was reached on 03/14/25, a 52-week low of $362.50 was recorded on 08/11/25.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 381.14, which if violated will result in even more drops to 376.55. On the upside, there is a resistance level at 388.90. A further resistance level may holdings at 392.07.
How much short interest is there in Vertex Pharmaceuticals, Inc?
A steep rise in short interest was recorded in Vertex Pharmaceuticals, Inc stocks on 2025-09-15, growing by 0.35 million shares to a total of 4.05 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 3.7 million shares. There was a rise of 8.71%, which implies that there is a positive sentiment for the stock.
